Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Drug Deliv. 2014 Jun 5;23(3):968–980. doi: 10.3109/10717544.2014.923068

Figure 9.

Figure 9

(A)T1 weighted images and (B) quantitative analysis of % tumor signal versus time of mice bearing subcutaneous SKOV3 tumor xenograft post i.v. injection of magnevist, non-targeted NEs and folate-targeted NEs with pemetrexed treatment at final concentration of Gd at 0.072 mmoles/kg, the data are shown as mean ±SD (n=3).